James Dodge
11Patents
4h-index
5Co-inventors
49Inventor score
Filing activity: Nov 2, 2007 → Mar 3, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9034836B2 | Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders | Chemistry; Metallurgy | 20 | Active |
| US8926967B2 | Intraventricular enzyme delivery for lysosomal storage diseases | Chemistry; Metallurgy | 11 | Active |
| US8796236B2 | Gene therapy for lysosomal storage diseases | Chemistry; Metallurgy | 10 | Active |
| US10080783B2 | Intraventricular enzyme delivery for lysosomal storage diseases | Chemistry; Metallurgy | 6 | Active |
| US10744210B2 | Gene therapy for spinal cord disorders | Chemistry; Metallurgy | 4 | Active |
| US11253485B2 | Slow intraventricular delivery | Chemistry; Metallurgy | 3 | Active |
| US10632213B2 | Gene therapy for neurometabolic disorders | Chemistry; Metallurgy | 1 | Active |
| US11369693B2 | Gene therapy for lysosomal storage diseases | Chemistry; Metallurgy | 0 | Active |
| US11957765B2 | Gene therapy for neurometabolic disorders | Chemistry; Metallurgy | 0 | Active |
| US10913956B2 | Gene therapy for neurometabolic disorders | Chemistry; Metallurgy | 0 | Active |
| US11554161B2 | Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.